<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>AARS1 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/aars1/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Oct 2026 17:24:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>AARS1 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Lactate-fueled enzyme rewrites gene expression to drive pulmonary arterial hypertension</title>
		<link>https://bioengineer.org/lactate-fueled-enzyme-rewrites-gene-expression-to-drive-pulmonary-arterial-hypertension/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 19 Oct 2026 17:24:14 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[AARS1]]></category>
		<category><![CDATA[arterial]]></category>
		<category><![CDATA[histone]]></category>
		<category><![CDATA[hypertension]]></category>
		<category><![CDATA[Lactate-driven]]></category>
		<category><![CDATA[lactylation]]></category>
		<category><![CDATA[promotes]]></category>
		<category><![CDATA[pulmonary]]></category>
		<category><![CDATA[scientific research]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=438483</guid>

					<description><![CDATA[Pulmonary arterial hypertension, a relentless and often fatal disease in which the blood vessels of the lungs progressively narrow and stiffen, has long resisted therapies that go beyond easing symptoms. Now a team of researchers working at Fujian Medical University]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">438483</post-id>	</item>
	</channel>
</rss>
